PLENARY LECTURE
-
Plenary Lecture 1
Lessons learned after 50+years of cancer drug development
Daniel D. Von Hoff
Translational Genomics Research Institute
USA
-
Plenary Lecture 2
Rapidly expanding treatment options in lung cancer
Sanjay Popat
The Royal Marsden Hospital
UK
-
Plenary Lecture 3
Cancer as a complex system:
Tumor-Stroma-Immune interactions
Linghua Wang
MD Anderson Cancer Center
USA
-
Plenary Lecture 4
Hepatocellular carcinoma:
What is the big picture? and are we seeing it?
Ghassan K. Abou-Alfa
Memorial Sloan Kettering Cancer Center
USA
SCIENTIFIC SYMPOSIUM
Scientific Symposium 1
Navigating current and emerging therapies
-
Yeon Hee Park
Samsung Medical Center
Republic of Korea
-
-
Scientific Symposium 2
Unlocking new immune checkpoint targets : Beyond PD-1/PD-L1 and CTLA4
-
Diwakar Davar
University of Pittsburgh
USA
-
Chan Kim
CHA Bundang Medical Center
Republic of Korea
-
-
Yun-Gyoo Lee
Kangbuk Samsung Hospital
Republic of Korea
Scientific Symposium 3
Crucible moments in oncology drug development: Translating biomarkers into breakthroughs
-
-
Paul Workman
The Institute of Cancer Research, London
UK
-
Scientific Symposium 4
The forthcoming future of genitourinary cancers
-
-
Se Hoon Park
Samsung Medical Center
Republic of Korea
-
-
Ji Hyun Park
Konkuk University Medical Center
Republic of Korea
Scientific Symposium 5
Emerging immunologic weapons beyond PD1, CTLA4, TIGIT, and LAG3 in lung cancer
-
Tae Min Kim
Seoul National University Hospital
Republic of Korea
-
-
Hye Ryun Kim
Yonsei Cancer Center
Republic of Korea
-
Patrick Ott
Dana-Farber Cancer Institute
USA
Scientific Symposium 6
Novel therapeutic approaches for GI cancers
-
David S. Hong
The University of Texas MD Anderson Cancer Center
USA
-
Choong-Kun Lee
Severance Hospital
Republic of Korea
-
Stephen L. Chan
Chinese University of Hong Kong
Hong Kong
-
Eileen M. O'Reilly
Memorial Sloan Kettering Cancer Center
USA
Scientific Symposium 7
Artificial intelligence-driven optimization drug development process: from target discovery to phase I trial
-
-
-
Jimmy Yen-Chu Lin
Insilico Medicine
Taiwan
-
Yi Rang Kim
Oncocross Co., Ltd
Republic of Korea
Scientific Symposium 8
Emerging ADC treatment across cancer types
-
Yong Wha Moon
CHA Bundang Medical Center
Republic of Korea
-
-
Toshio Shimizu
Wakayama Medical University
Japan
-
Gottfried Konecny
UCLA
USA
Joint Symposium
Joint Symposium 1 (ASCO/KSMO)
Oncology innovations in cancer care - translating new discoveries into treatment for patients with cancer
-
Angela DeMichele
University of Pennsylvania
USA
-
Rachna Shroff
University of Arizona College of Medicine
USA
-
Minsuk Kwon
Ajou University Medical Center
Republic of Korea
-
Se-Hoon Lee
Samsung Medical Center
Republic of Korea
Joint Symposium 2 (KCSG/KSMO)
Breakthrough of drug development in rare cancers
-
Eun Joo Kang
Korea University Guro Hospital
Republic of Korea
-
Peter J O'Dwyer
University of Pennsylvania
USA
-
Bhumsuk Keam
Seoul National University Hospital
Republic of Korea
-
Konstantin Dragnev
Dartmouth Cancer Center
USA
Joint Symposium 3 (ESMO/KSMO)
Emerging issues in the treatment of colon and rectal cancers
-
-
Myriam Chalabi
Netherlands Cancer Institute
Netherlands
-
Sun Young Kim
Asan Medical Center
Republic of Korea
-
Andrés Cervantes
University of Valencia
Spain
Joint Symposium 4 (KSR/KSMO)
AI application on oncology imaging
-
Hyungjin Kim
Seoul National University Hospital
Republic of Korea
-
Jung Hyun Yoon
Severance Hospital
Republic of Korea
-
Joint Symposium 5 (JSMO/KSMO)
Moving the immune checkpoint inhibitors into the partner of surgery
-
-
Jeong Eun Kim
Asan Medical Center
Republic of Korea
-
Hidehito Horinouchi
National Cancer Center Hospital
Department of Thoracic Oncology
Japan
-
Ken Kato
National Cancer Center Hospital
Japan
Joint Symposium 6 (KSP/KSMO)
Application of digital pathology in precision medicine: Current and future
-
Yoon-La Choi
Samsung Medical Center
Republic of Korea
-
Matthew Hanna
Memorial Sloan Kettering Cancer Center
USA
-
David Joon Ho
National Cancer Center Korea
Republic of Korea
-
Anil Parwani
Ohio State University
USA
Joint Symposium 7 (ASCO/KSMO)
Optimal palliative care for cancer patients
-
Lynn M. Schuchter
American Society of Clinical Oncology
USA
-
Thomas Leblanc
Duke Department of Medicine
USA
-
Jung Yong Hong
Samsung Medical Center
Republic of Korea
-
Jung Hun Kang
Gyeongsang National University
Republic of Korea
Joint Symposium 8 (KSSO/KSMO)
Conversion surgery and optimal timing of systemic therapy for GI cancer
-
Junichi Shindoh
Toranomon Hospita
Japan
-
Tai Wai Meng David
National Cancer Centre
Singapore
-
-
Joint Symposium 9 (ESMO/KSMO)
New horizon in GI cancer
-
-
Julien Taieb
Université Paris Descartes
France
-
-
Joint Symposium 10 (KOSRO/KSMO)
Integration of systemic therapy and radiotherapy
-
Icro Meatinni
University of Florence
Italy
-
Rodney Cheng-En Hsieh
Chang Gung Memorial Hospital
Taiwan
-
Sun Min Lim
Yonsei Cancer Center
Republic of Korea
MULTI-DISCIPLINARY CASE DISCUSSION
Multi-Disciplinary Case Discussion (KOREAN)
Optimization of treatment for BRPC/LAPC
-
-
In Woong Han
Samsung Medical Center
Republic of Korea
-
Eui Kyu Chie
Seoul National University Hospital
Republic of Korea
EDUCATION SESSION
Education Session 1 (KOREAN)
ABCs of toxicities management for medical oncologist: Our OLD and NEW foes
-
Sung Hoon Kim
Asan Medical Center
Republic of Korea
-
Su-Hyun Kim
National Cancer Center
Republic of Korea
-
-
Se Hyun Kim
Seoul National University Bundang Hospital
Republic of Korea
Education Session 2 (KOREAN)
Early integration of palliative care
-
Yu Jung Kim
Seoul National University Bundang Hospital
Republic of Korea
-
Shin Hye Yoo
Seoul National University Hospital
Republic of Korea
-
Seockhoon Chung
Asan Medical Center
Republic of Korea
-
Su-Jin Koh
Ulsan University Hospital
Republic of Korea
Education Session 3 (KOREAN)
Technologies revolutionizing cancer treatment and care
-
-
Seung Yoon Yang
Severance Hospital
Republic of Korea
-
Ju Hee Cho
Samsung Medical Center
Republic of Korea
